{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:29:49Z","timestamp":1781879389736,"version":"3.54.5"},"reference-count":90,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Enteralia Bioscience"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Familial adenomatous polyposis (FAP) is a rare disease characterized by the development of adenomatous polyps in the colon and rectum already in adolescence. If left untreated, patients develop colorectal cancer (CRC) with a 100% probability. To date, the gold standard of FAP management is surgery, which is associated with morbidity and mortality. A chemopreventive agent capable of delaying, preventing and reversing the development of CRC has been sought. Several classes of drugs have been used but to date no chemopreventive drug has been found for the management of this disease. In recent years, the importance of estrogen receptors in FAP and CRC, particularly the \u03b2 subtype, has emerged. Indeed, the expression of the latter is strongly reduced in adenomatous polyps and CRC and is inversely correlated with the aggressiveness of the disease. Since phytoestrogens have a high affinity for this receptor, they have been suggested for use as chemopreventive agents in FAP and CRC. A combination of phytoestrogens and insoluble fibres has proved particularly effective. In this review, the various mechanisms of action of phytoestrogens were analyzed and the effectiveness of using phytoestrogens as an effective chemopreventive strategy was discussed.<\/jats:p>","DOI":"10.3390\/pharmaceutics16050640","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T09:22:52Z","timestamp":1715332972000},"page":"640","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mechanisms of Action of Phytoestrogens and Their Role in Familial Adenomatous Polyposis"],"prefix":"10.3390","volume":"16","author":[{"given":"Irene","family":"Falsetti","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-7404","authenticated-orcid":false,"given":"Gaia","family":"Palmini","sequence":"additional","affiliation":[{"name":"Fondazione Italiana Ricerca sulle Malattie dell\u2019Osso (FIRMO Onlus), 50129 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7461-330X","authenticated-orcid":false,"given":"Teresa","family":"Iantomasi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria","family":"Brandi","sequence":"additional","affiliation":[{"name":"Fondazione Italiana Ricerca sulle Malattie dell\u2019Osso (FIRMO Onlus), 50129 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Fondazione Italiana Ricerca sulle Malattie dell\u2019Osso (FIRMO Onlus), 50129 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/BJN20061868","article-title":"The potential of nuts in the prevention of cancer","volume":"96","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"594656","DOI":"10.1155\/2015\/594656","article-title":"Modulation of aromatase by phytoestrogens","volume":"2015","author":"Lephart","year":"2015","journal-title":"Enzym. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000083773","article-title":"Health effects of phytoestrogens","volume":"57","author":"Branca","year":"2005","journal-title":"Forum Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Viggiani, M.T., Polimeno, L., Di Leo, A., and Barone, M. (2019). Phytoestrogens: Dietary intake, bioavailability, and protective mechanisms against colorectal neoproliferative lesions. Nutrients, 11.","DOI":"10.3390\/nu11081709"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2174\/1381612826999200917154747","article-title":"Beneficiary and adverse effects of phytoestrogens: A potential constituent of plant-based diet","volume":"27","author":"Sridevi","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lecomte, S., Demay, F., Ferri\u00e8re, F., and Pakdel, F. (2017). Phytochemicals targeting estrogen receptors: Beneficial rather than adverse effects?. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071381"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/ptr.6419","article-title":"Polyphenols: A concise overview on the chemistry, occurrence, and human health","volume":"33","author":"Durazzo","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Seyed Hameed, A.S., Rawat, P.S., Meng, X., and Liu, W. (2020). Biotransformation of dietary phytoestrogens by gut microbes: A review on bidirectional interaction between phytoestrogen metabolism and gut microbiota. Biotechnol. Adv., 43.","DOI":"10.1016\/j.biotechadv.2020.107576"},{"key":"ref_9","first-page":"S401","article-title":"Phytoestrogens and the intestinal microbiome","volume":"67","year":"2018","journal-title":"Physiol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.12.009","article-title":"Estrogen receptor beta as target for colorectal cancer prevention","volume":"372","author":"Williams","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsbmb.2013.03.003","article-title":"Estrogen receptor beta: Tissue distribution and the still largely enigmatic physiological function","volume":"139","author":"Thelen","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen-gut microbiome axis: Physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"ref_13","first-page":"801","article-title":"Cancer therapy using natural ligands that target estrogen receptor beta","volume":"13","author":"Sareddy","year":"2015","journal-title":"Chin. J. Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.3748\/wjg.v20.i33.11496","article-title":"Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role?","volume":"20","author":"Principi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1007\/s11033-020-05414-6","article-title":"Targeting estrogen receptors in colorectal cancer","volume":"47","author":"Maingi","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12263-008-0081-6","article-title":"Estrogens, phytoestrogens and colorectal neoproliferative lesions","volume":"3","author":"Barone","year":"2008","journal-title":"Genes Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejphar.2014.07.057","article-title":"Phytoestrogens and their effects","volume":"741","author":"Sirotkin","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Torrens-Mas, M., and Roca, P. (2020). Phytoestrogens for cancer prevention and treatment. Biology, 9.","DOI":"10.3390\/biology9120427"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Jang, W.Y., Kim, M.Y., and Cho, J.Y. (2022). Antioxidant, anti-inflammatory, anti-menopausal, and anti-cancer effects of lignans and their metabolites. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415482"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11030-022-10399-4","article-title":"Targeting UNC-51-like kinase 1 and 2 by lignans to modulate autophagy: Possible implications in metastatic colorectal cancer","volume":"27","author":"Sain","year":"2023","journal-title":"Mol. Divers."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1039\/D2FO00345G","article-title":"Sesamin inhibits hypoxia-stimulated angiogenesis via the NF-\u03baB p65\/HIF-1\u03b1\/VEGFA signaling pathway in human colorectal cancer","volume":"13","author":"Huang","year":"2022","journal-title":"Food Func."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bph.13622","article-title":"The potential health effects of dietary phytoestrogens","volume":"174","author":"Rietjens","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.dld.2007.10.018","article-title":"ER-beta expression in large bowel adenomas: Implications in colon carcinogenesis","volume":"40","author":"Barone","year":"2008","journal-title":"Dig. Liver Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3109\/00365521.2010.487915","article-title":"ER\u03b2 expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis","volume":"45","author":"Barone","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12029-011-9332-7","article-title":"Dietary, endocrine, and metabolic factors in the development of colorectal cancer","volume":"43","author":"Barone","year":"2012","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10552-004-3488-4","article-title":"Hereditary colorectal cancer syndromes","volume":"16","author":"Strate","year":"2005","journal-title":"Cancer Causes Control."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12094-010-0517-5","article-title":"TTD consensus document on the diagnosis and management of hereditary colorectal cancer","volume":"12","author":"Segura","year":"2010","journal-title":"Clin. Transl. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2003.027771","article-title":"Duodenal adenomatosis in familial adenomatous polyposis","volume":"53","author":"Christensen","year":"2004","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10689-016-9905-5","article-title":"Familial adenomatous polyposis in pediatrics: Natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate","volume":"15","author":"Septer","year":"2016","journal-title":"Fam. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2007.136127","article-title":"Guidelines for the clinical management of familial adenomatous polyposis (FAP)","volume":"57","author":"Vasen","year":"2008","journal-title":"Gut"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/bjs.4094","article-title":"Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis","volume":"90","author":"Berk","year":"2003","journal-title":"Br. J. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1572-0241.2006.00375.x","article-title":"Familial adenomatous polyposis","volume":"101","author":"Galiatsatos","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cgh.2010.04.008","article-title":"Jejunal cancer in patients with familial adenomatous polyposis","volume":"8","author":"Ruys","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000362575","article-title":"Hereditary Factors in Esophageal Adenocarcinoma","volume":"1","author":"Dinjens","year":"2014","journal-title":"Gastrointest. Tumors"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10689-013-9638-7","article-title":"Barrett\u2019s esophagus in the patients with familial adenomatous polyposis","volume":"13","author":"Gatalica","year":"2014","journal-title":"Fam. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.seminoncol.2004.09.038","article-title":"Colorectal cancer prevention: Is an ounce of prevention worth a pound of cure?","volume":"32","author":"Gill","year":"2005","journal-title":"Semin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1079\/PNS2002236","article-title":"Can resistant starch and\/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 Study","volume":"62","author":"Mathers","year":"2003","journal-title":"Proc. Nutr. Soc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/excr.2000.5142","article-title":"The many faces of the tumor suppressor gene APC","volume":"264","author":"Giles","year":"2001","journal-title":"Exp. Cell Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1242\/jcs.100479","article-title":"Interactions and functions of the adenomatous polyposis coli (APC) protein at a glance","volume":"126","author":"Nelson","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1242\/jcs.01313","article-title":"APC at a glance","volume":"117","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1200\/JCO.2000.18.9.1967","article-title":"Biology of the adenomatous polyposis coli tumor suppressor","volume":"18","author":"Goss","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"21327","DOI":"10.18632\/oncotarget.15570","article-title":"A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gut.48.4.515","article-title":"Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families","volume":"48","author":"Friedl","year":"2001","journal-title":"Gut"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2003.09.118","article-title":"Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis","volume":"21","author":"Bertario","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1897-4287-11-13","article-title":"Thyroid cancer complicating familial adenomatous polyposis: Mutation spectrum of at-risk individuals","volume":"11","author":"Septer","year":"2013","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41395-018-0278-2","article-title":"Web-Based Model for Predicting Time to Surgery in Young Patients with Familial Adenomatous Polyposis: An Internally Validated Study","volume":"113","author":"Sarvepalli","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.23922\/jarc.2017-007","article-title":"Alternative treatments for prophylaxis of colorectal cancer in familial adenomatous polyposis","volume":"1","author":"Takeshita","year":"2018","journal-title":"J. Anus Rectum Colon"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jso.20672","article-title":"Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis","volume":"95","author":"Valanzano","year":"2007","journal-title":"J. Surg. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10147-016-0977-x","article-title":"Feasibility of laparoscopic total proctocolectomy with ileal pouch-anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: Results of a nationwide multicenter study","volume":"21","author":"Konishi","year":"2016","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/BF02235487","article-title":"Outcome of primary and secondary ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis","volume":"44","author":"Akerbrant","year":"2001","journal-title":"Dis. Colon Rectum"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/bjs.4082","article-title":"Female fecundity before and after operation for familial adenomatous polyposis","volume":"90","author":"Olsen","year":"2003","journal-title":"Br. J. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10689-020-00189-y","article-title":"Chemoprevention in familial adenomatous polyposis: Past, present and future","volume":"20","author":"Mankaney","year":"2021","journal-title":"Fam. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0165-6147(02)00043-3","article-title":"Cyclooxygenase 2: A molecular target for cancer prevention and treatment","volume":"24","author":"Subbaramaiah","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14656560802560153","article-title":"Colon cancer: Preventive agents and the present status of chemoprevention","volume":"10","author":"Half","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/1568026054201631","article-title":"Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer","volume":"5","author":"Benamouzig","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(08)61490-7","article-title":"Cardiovascular events associated with rofecoxib: Final analysis of the APPROVe trial","volume":"372","author":"Baron","year":"2008","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.108.764530","article-title":"Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: The cross trial safety analysis","volume":"117","author":"Solomon","year":"2008","journal-title":"Circulation"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"101793","DOI":"10.1016\/j.bpg.2022.101793","article-title":"Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights","volume":"58\u201359","author":"Aelvoet","year":"2022","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_61","first-page":"945","article-title":"Development of difluoromethylornithine (DFMO) as a chemoprevention agent","volume":"5","author":"Meyskens","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-3-642-30331-9_8","article-title":"Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasia","volume":"191","author":"Hull","year":"2013","journal-title":"Recent Results Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.2174\/092986707782793934","article-title":"n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: Molecular mechanisms involved","volume":"14","author":"Calviello","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOG.0b013e32801145d7","article-title":"Colon cancer, fatty acids and anti-inflammatory compounds","volume":"23","author":"Chapkin","year":"2007","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/carcin\/24.3.385","article-title":"The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines","volume":"24","author":"Dommels","year":"2003","journal-title":"Carcinogenesis"},{"key":"ref_66","first-page":"1386","article-title":"Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: Mediation through cyclooxygenase-independent pathways","volume":"61","author":"Boudreau","year":"2001","journal-title":"Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/carcin\/bgx136","article-title":"A novel bioactive derivative of eicosapentaenoic acid (EPA) suppresses intestinal tumor development in Apc\u039414\/+ mice","volume":"39","author":"Nakanishi","year":"2018","journal-title":"Carcinogenesis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.3748\/wjg.v22.i11.3202","article-title":"Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors?","volume":"22","author":"Nesi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019473","article-title":"Phytoestrogens and Related Food Components in the Prevention of Cancer","volume":"27","author":"Qadir","year":"2017","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/carcin\/bgh346","article-title":"Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min\/+) mouse model of colorectal cancer","volume":"26","author":"Javid","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3835(98)00139-6","article-title":"The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse","volume":"130","author":"Kristiansen","year":"1998","journal-title":"Cancer Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0960-0760(03)00270-X","article-title":"Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats","volume":"86","author":"Becker","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.10625","article-title":"Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats","volume":"101","author":"Kohno","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/carcin\/bgp275","article-title":"Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin\/+ mice","volume":"31","author":"Barone","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S0007114512000876","article-title":"Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT\/\u03b2-catenin signalling and reduces colon pre-neoplasia in rats","volume":"109","author":"Zhang","year":"2013","journal-title":"Br. J. Nutr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s13577-012-0051-6","article-title":"Effects of genistein and daidzein on cell proliferation kinetics in HT29 colon cancer cells: The expression of CTNNBIP1 (\u03b2-catenin), APC (adenomatous polyposis coli) and BIRC5 (survivin)","volume":"27","author":"Lepri","year":"2014","journal-title":"Hum. Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"211S","DOI":"10.1093\/jn\/137.1.211S","article-title":"Gender-specific modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon","volume":"137","author":"Bises","year":"2007","journal-title":"J. Nutr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00394-004-0521-z","article-title":"No effect on adenoma formation in Min mice after moderate amount of flaxseed","volume":"44","author":"Oikarinen","year":"2005","journal-title":"Eur. J. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1207\/S15327914NC4502_10","article-title":"Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice","volume":"45","author":"Mortensen","year":"2003","journal-title":"Nutr. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3748\/wjg.v26.i14.1601","article-title":"Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model","volume":"26","author":"Girardi","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1079\/BJN20051535","article-title":"Effects of a flaxseed mixture and plant oils rich in alpha-linolenic acid on the adenoma formation in multiple intestinal neoplasia (Min) mice","volume":"94","author":"Oikarinen","year":"2005","journal-title":"Br. J. Nutr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/carcin\/bgi089","article-title":"Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin)","volume":"26","author":"Volate","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1158\/0008-5472.CAN-09-3249","article-title":"Chemoprevention of intestinal tumorigenesis in APCmin\/+ mice by silibinin","volume":"70","author":"Rajamanickam","year":"2010","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1158\/1078-0432.CCR-10-1213","article-title":"Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A\/J mice","volume":"16","author":"Ravichandran","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.3748\/wjg.v19.i27.4325","article-title":"Phytoestrogens\/insoluble fibers and colonic estrogen receptor \u03b2: Randomized, double-blind, placebo-controlled study","volume":"19","author":"Principi","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.3748\/wjg.v19.i34.5671","article-title":"Eviendep\u00ae reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis","volume":"19","author":"Calabrese","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jgh.12912","article-title":"Education and imaging. Gastroenterology: Video capsule endoscopy disclosure of unprecedented therapeutic effect of Eviendep on small bowel polyposis in Lynch syndrome","volume":"30","author":"Bringiotti","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/carcin\/bgw041","article-title":"Can supplementation of phytoestrogens\/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis?","volume":"37","author":"Calabrese","year":"2016","journal-title":"Carcinogenesis"},{"key":"ref_89","first-page":"79","article-title":"Low intestinal tract adenomatous polyps regression in FAP patients by dietary-induced erbeta upregulation","volume":"15","author":"Tonelli","year":"2018","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/CEJ.0000000000000542","article-title":"Supplementation with phytoestrogens and insoluble fibers reduces intestinal carcinogenesis and restores ER-\u03b2 expression in Apc-driven colorectal carcinogenesis","volume":"29","author":"Luceri","year":"2020","journal-title":"Eur. J. Cancer Prev."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/5\/640\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:43:31Z","timestamp":1760107411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/5\/640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":90,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["pharmaceutics16050640"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16050640","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]}}}